Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Onyx Pharmaceuticals Inc. has a market cap of $1.87 billion; its shares were traded at around $29.78 with a P/E ratio of 54.1 and P/S ratio of 7.4.
ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Columbia Wanger of Columbia Wanger Asset Management, Paul Tudor Jones of The Tudor Group, Steven Cohen of SAC Capital Advisors.
This is the annual revenues and earnings per share of ONXX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ONXX.
CEO Recent Trades:
- Sell: President & CEO N Anthony Coles sold 20,000 shares of ONXX stock on 08/19/2010 at the average price of 26.4. N Anthony Coles owns at least 63,302 shares after this. The price of the stock has increased by 12.8% since.
This is the insider trade history vs. stock price of ONXX. For the complete insider trading history of ONXX, click here.
Directors and Officers Recent Trades:
- Sell: SVP, Corporate Development Juergen Lasowski sold 600 shares of ONXX stock on 05/20/2010 at the average price of 24.06. Juergen Lasowski owns at least 13,861 shares after this. The price of the stock has increased by 23.77% since.
Subscribe RSS
RSS